Albert Missbichler

This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Sciotec Diagnostic Technologies Gmbh, Stada Arzneimittel Ag, Immundiagnostik Ag. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Albert Missbichler. Retrieved from https://idiyas.com/inventor/albert-missbichler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

4 out of 4

Sciotec Diagnostic Technologies Gmbh

patents

2 out of 3

Stada Arzneimittel Ag

Years Active: 2010-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10898464 - Tannin and anti-gliadin antibody compositions for treatment of a disease of the intestinal tract (2021-01-26),

2. 9724326 - Method of treating celiac disease (2017-08-08),

3. 9364437 - Diaminooxidase-containing pharmaceutical compositions (2016-06-14),

4. 9144602 - Treatment of fructose malabsorption (2015-09-29),

5. 8716244 - Diaminooxidase-containing pharmaceutical compositions (2014-05-06),

6. 8003343 - Method for determining diamine oxidase (2011-08-23),

7. 7851163 - Method for determining the biologically effective parathyroid hormone activity in a sample (2010-12-14),

Title: Albert Missbichler: Innovator in Intestinal Health

Introduction

Albert Missbichler is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medical science, particularly in the treatment of intestinal disorders. With a total of seven patents to his name, Missbichler's work focuses on innovative solutions for health challenges related to gluten-associated proteins.

Latest Patents

Among his latest patents is a composition for the treatment of intestinal tract disorders caused by gluten-associated proteins. This invention involves a composition that includes at least one agent binding to the gluten-associated protein, administered alongside tannins to enhance efficacy. Another significant patent is a method for treating celiac disease, which similarly utilizes a composition designed to address gluten-related health issues.

Career Highlights

Throughout his career, Albert Missbichler has worked with prominent companies in the medical field. Notably, he has been associated with Sciotec Diagnostic Technologies GmbH and Stada Arzneimittel AG. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Missbichler has collaborated with esteemed colleagues, including Franz Gabor and Herwig Ernst Reichl. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medical innovation.

Conclusion

Albert Missbichler stands out as a key figure in the realm of medical inventions, particularly in addressing gluten-related disorders. His patents and collaborations reflect a commitment to improving health outcomes through innovative solutions.

Profile summary based on public USPTO records.